Difference in precocious puberty between pre–COVID-19 and COVID-19 periods: a meta-analysis - Scorecard - MDSpire

Difference in precocious puberty between pre–COVID-19 and COVID-19 periods: a meta-analysis

  • By

  • Nam Nhat Nguyen

  • Tri Dang Do

  • Hieu Hong Truong

  • Anh Nam Mai

  • Yang-Ching Chen

  • August 21, 2024

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Precocious Puberty Incidence Before and During the COVID-19 Pandemic: A Meta-Study

At a Glance

CategoryDetail
ConditionPrecocious puberty (central type), premature onset of puberty before age 8 in girls or 9 in boys
Key MechanismsActivation of hypothalamic–pituitary-gonadal axis; influenced by adiposity, childhood adversities, sleep patterns, and environmental factors
Target PopulationChildren presenting for suspected precocious puberty
Care SettingPediatric endocrinology clinics

Key Highlights

  • COVID-19 pandemic associated with nearly doubled odds of precocious puberty incidence among referred children (OR=1.96; 95% CI 1.56-2.47).
  • Age at presentation was lower during the pandemic period; BMI standard deviation scores did not differ significantly between periods.
  • Precocious puberty incidence increased more rapidly during the pandemic compared to the prepandemic period.

Guideline-Based Recommendations

Diagnosis

  • Early and accurate diagnosis of central precocious puberty is crucial to prevent adverse outcomes.
  • Consider evaluation of age at presentation and clinical signs consistent with hypothalamic–pituitary-gonadal axis activation.

Management

  • Address modifiable risk factors such as adiposity and lifestyle changes.
  • Monitor and manage psychosocial challenges associated with precocious puberty.

Monitoring & Follow-up

  • Regular follow-up to assess pubertal progression and treatment response.
  • Monitor BMI and growth parameters during management.

Risks

  • Untreated precocious puberty may lead to compromised adult health, increased cardiometabolic disease risk, certain cancers, behavioral disorders, and psychosocial issues.

Patient & Prescribing Data

Children with suspected central precocious puberty presenting to pediatric endocrinology clinics before and during the COVID-19 pandemic.

No direct treatment data reported; emphasis on early diagnosis and addressing contributing factors such as adiposity and lifestyle.

Clinical Best Practices

  • Maintain vigilance for increased incidence of precocious puberty during and after pandemic-related disruptions.
  • Incorporate assessment of environmental and lifestyle factors potentially influencing pubertal timing.
  • Educate families about the importance of timely medical evaluation for early pubertal signs despite pandemic constraints.

References

Original Source(s)

Related Content